T1	Participants 650 885	Twenty healthy volunteers were randomized to a double-blind, placebo-controlled, crossover study to determine if omeprazole, 40 mg/day prevents gastroduodenal injury due to two weeks of aspirin administration (650 mg four times a day).
T2	Participants 1002 1086	Fourteen of the 20 subjects had less gastric injury during cotherapy with omeprazole
T3	Participants 1092 1177	six with no difference received aspirin plus omeprazole in the first treatment period
